デフォルト表紙
市場調査レポート
商品コード
755015

世界の複合アッセイ市場:企業プロファイル、規模、シェア、成長、動向、予測

Global Multiplex Assays Market: Companies Profiles, Size, Share, Growth, Trends and Forecast to 2026

出版日: | 発行: Data Bridge Market Research Private Limited | ページ情報: 英文 320 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=116.46円
世界の複合アッセイ市場:企業プロファイル、規模、シェア、成長、動向、予測
出版日: 2018年11月01日
発行: Data Bridge Market Research Private Limited
ページ情報: 英文 320 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の複合アッセイ市場について調査し、市場の動向とセグメント別概要、地域別動向、および市場に参入主要企業のプロファイルについてまとめています。

第1章 イントロダクション

第2章 市場セグメンテーション

第3章 市場概要

  • 促進因子
  • 阻害因子
  • 機会
  • 課題

第4章 エグゼクティブサマリー

第5章 プレミアムインサイト

第6章 製品・サービス別市場

  • 概要
  • 試薬・消耗品
  • 計器・アクセサリ
  • ソフトウェア・サービス

第7章 タイプ別市場

  • 概要
  • 核酸複合アッセイ
  • タンパク質複合アッセイ
  • セルベース複合アッセイ

第8章 技術別市場

  • 概要
  • タンパク質マイクロアレイ
  • ポリメラーゼ連鎖反応
  • 複合リアルタイムPCR
  • フローサイトメトリー
  • 蛍光検出
  • 発光
  • その他

第9章 用途別市場

  • 概要
  • 臨床診断
  • 研究開発

第10章 エンドユーザー別市場

  • 概要
  • 病院
  • 臨床試験所
  • 製薬会社・バイオテクノロジー企業
  • 研究機関
  • その他

第11章 地域別市場

  • 概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • 南米
  • 中東・アフリカ

第12章 競合環境

第13章 企業プロファイル

第14章 関連レポート

図表

LIST OF TABLES

  • TABLE 1 COST OF FEW MULTIPLEX INSTRUMENTS 49
  • TABLE 2 GLOBAL MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) 63
  • TABLE 3 GLOBAL REAGENTS & CONSUMABLES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 63
  • TABLE 4 GLOBAL INSTRUMENTS & ACCESSORIES IN MULTIPLEX ASSAYS MARKET,

BY REGION, 2017-2026 (USD MILLION) 64

  • TABLE 5 GLOBAL INSTRUMENTS & ACCESSORIES IN MULTIPLEX ASSAYS MARKET,

BY REGION, 2017-2026 (USD MILLION) 64

  • TABLE 6 GLOBAL MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 67
  • TABLE 7 GLOBAL NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY TYPE,

2017-2026 (USD MILLION) 67

  • TABLE 8 GLOBAL NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY REGION,

2017-2026 (USD MILLION) 68

  • TABLE 9 GLOBAL PROTEIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 69
  • TABLE 10 GLOBAL PROTEIN MULTIPLEX ASSAYS MARKET, BY REGION,

2017-2026 (USD MILLION) 69

  • TABLE 11 GLOBAL CELL-BASED MULTIPLEX ASSAYS MARKET, BY REGION,

2017-2026 (USD MILLION) 70

  • TABLE 12 GLOBAL MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 73
  • TABLE 13 GLOBAL PROTEIN MICROARRAY IN MULTIPLEX ASSAYS MARKET,

BY REGION, 2017-2026 (USD MILLION) 73

  • TABLE 14 GLOBAL POLYMERASE CHAIN REACTION IN MULTIPLEX ASSAYS MARKET,

BY REGION, 2017-2026 (USD MILLION) 74

  • TABLE 15 GLOBAL MULTIPLEX REAL-TIME PCR IN MULTIPLEX ASSAYS MARKET,

BY REGION, 2017-2026 (USD MILLION) 74

  • TABLE 16 GLOBAL FLOW CYTOMETRY IN MULTIPLEX ASSAYS MARKET, BY REGION,

2017-2026 (USD MILLION) 75

  • TABLE 17 GLOBAL FLUORESCENCE DETECTION IN MULTIPLEX ASSAYS MARKET,

BY REGION, 2017-2026 (USD MILLION) 75

  • TABLE 18 GLOBAL LUMINESCENCE IN MULTIPLEX ASSAYS MARKET, BY REGION,

2017-2026 (USD MILLION) 76

  • TABLE 19 GLOBAL OTHERS IN MULTIPLEX ASSAYS MARKET, BY REGION,

2017-2026 (USD MILLION) 76

  • TABLE 20 GLOBAL MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 79
  • TABLE 21 GLOBAL CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY REGION, 2017-2026 (USD MILLION) 79

  • TABLE 22 GLOBAL CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 80

  • TABLE 23 GLOBAL RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY REGION, 2017-2026 (USD MILLION) 81

  • TABLE 24 GLOBAL RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 82

  • TABLE 25 GLOBAL MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 85
  • TABLE 26 GLOBAL HOSPITALS IN MULTIPLEX ASSAYS MARKET, BY REGION,

2017-2026 (USD MILLION) 85

  • TABLE 27 GLOBAL CLINICAL LABORATORIES IN MULTIPLEX ASSAYS MARKET,

BY REGION, 2017-2026 (USD MILLION) 86

  • TABLE 28 GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 86
  • TABLE 29 GLOBAL RESEARCH INSTITUTES IN MULTIPLEX ASSAYS MARKET,

BY REGION, 2017-2026 (USD MILLION) 87

  • TABLE 30 GLOBAL OTHERS IN MULTIPLEX ASSAYS MARKET, BY REGION,

2017-2026 (USD MILLION) 87

  • TABLE 31 GLOBAL MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) 93
  • TABLE 32 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY REGION,

2017-2026 (USD MILLION) 97

  • TABLE 33 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 97

  • TABLE 34 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 97
  • TABLE 35 NORTH AMERICA NUCLEIC ACID MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 98

  • TABLE 36 NORTH AMERICA PROTEIN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 98

  • TABLE 37 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,

2017-2026 (USD MILLION) 99

  • TABLE 38 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY APPLICATION,

2017-2026 (USD MILLION) 99

  • TABLE 39 NORTH AMERICA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 100

  • TABLE 40 NORTH AMERICA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 100

  • TABLE 41 NORTH AMERICA MULTIPLEX ASSAYS MARKET, BY END USER,

2017-2026 (USD MILLION) 101

  • TABLE 42 U.S. MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 102

  • TABLE 43 U.S. MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 102
  • TABLE 44 U.S. NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 103

  • TABLE 45 U.S. PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 103

  • TABLE 46 U.S. MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 104
  • TABLE 47 U.S. MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 104
  • TABLE 48 U.S. CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 105

  • TABLE 49 U.S. RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 105

  • TABLE 50 U.S. MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 106
  • TABLE 51 CANADA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 107

  • TABLE 52 CANADA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 107
  • TABLE 53 CANADA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 108

  • TABLE 54 CANADA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 108

  • TABLE 55 CANADA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 109
  • TABLE 56 CANADA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 109
  • TABLE 57 CANADA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 110

  • TABLE 58 CANADA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 110

  • TABLE 59 CANADA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 111
  • TABLE 60 MEXICO MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 112

  • TABLE 61 MEXICO MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 112
  • TABLE 62 MEXICO NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 113

  • TABLE 63 MEXICO PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 113

  • TABLE 64 MEXICO MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 114
  • TABLE 65 MEXICO MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 114
  • TABLE 66 MEXICO CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 115

  • TABLE 67 MEXICO RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 115

  • TABLE 68 MEXICO MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 116
  • TABLE 69 EUROPE MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 120
  • TABLE 70 EUROPE MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 120

  • TABLE 71 EUROPE MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 121
  • TABLE 72 EUROPE NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 121

  • TABLE 73 EUROPE PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 121

  • TABLE 74 EUROPE MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 122
  • TABLE 75 EUROPE MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 122
  • TABLE 76 EUROPE CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 123

  • TABLE 77 EUROPE RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 123

  • TABLE 78 EUROPE MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 124
  • TABLE 79 GERMANY MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 125

  • TABLE 80 GERMANY MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 125
  • TABLE 81 GERMANY NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 126

  • TABLE 82 GERMANY PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 126

  • TABLE 83 GERMANY MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,

2017-2026 (USD MILLION) 127

  • TABLE 84 GERMANY MULTIPLEX ASSAYS MARKET, BY APPLICATION,

2017-2026 (USD MILLION) 127

  • TABLE 85 GERMANY CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 128

  • TABLE 86 GERMANY RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 128

  • TABLE 87 GERMANY MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 129
  • TABLE 88 U.K. MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 130

  • TABLE 89 U.K. MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 131
  • TABLE 90 U.K. NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 131

  • TABLE 91 U.K. PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 131

  • TABLE 92 U.K. MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 132
  • TABLE 93 U.K. MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 132
  • TABLE 94 U.K. CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 133

  • TABLE 95 U.K. RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 133

  • TABLE 96 U.K. MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 134
  • TABLE 97 FRANCE MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 135

  • TABLE 98 FRANCE MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 135
  • TABLE 99 FRANCE NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 136

  • TABLE 100 FRANCE PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 136

  • TABLE 101 FRANCE MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 137
  • TABLE 102 FRANCE MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 137
  • TABLE 103 FRANCE CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 138

  • TABLE 104 FRANCE RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 138

  • TABLE 105 FRANCE MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 139
  • TABLE 106 ITALY MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 140

  • TABLE 107 ITALY MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 141
  • TABLE 108 ITALY NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 141

  • TABLE 109 ITALY PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 142

  • TABLE 110 ITALY MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 142
  • TABLE 111 ITALY MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 143
  • TABLE 112 ITALY CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 143

  • TABLE 113 ITALY RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 144

  • TABLE 114 ITALY MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 144
  • TABLE 115 SPAIN MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 145

  • TABLE 116 SPAIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 145
  • TABLE 117 SPAIN NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 146

  • TABLE 118 SPAIN PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 146

  • TABLE 119 SPAIN MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 147
  • TABLE 120 SPAIN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 147
  • TABLE 121 SPAIN CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 148
  • TABLE 122 SPAIN RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 148

  • TABLE 123 SPAIN MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 149
  • TABLE 124 SWITZERLAND MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 150

  • TABLE 125 SWITZERLAND MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 150
  • TABLE 126 SWITZERLAND NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 151
  • TABLE 127 SWITZERLAND PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 151

  • TABLE 128 SWITZERLAND MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,

2017-2026 (USD MILLION) 152

  • TABLE 129 SWITZERLAND MULTIPLEX ASSAYS MARKET, BY APPLICATION,

2017-2026 (USD MILLION) 152

  • TABLE 130 SWITZERLAND CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 153

  • TABLE 131 SWITZERLAND RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 153

  • TABLE 132 SWITZERLAND MULTIPLEX ASSAYS MARKET, BY END USER,

2017-2026 (USD MILLION) 154

  • TABLE 133 NETHERLANDS MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 155

  • TABLE 134 NETHERLANDS MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 155
  • TABLE 135 NETHERLANDS NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 156
  • TABLE 136 NETHERLANDS PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 156

  • TABLE 137 NETHERLANDS MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,

2017-2026 (USD MILLION) 157

  • TABLE 138 NETHERLANDS MULTIPLEX ASSAYS MARKET, BY APPLICATION,

2017-2026 (USD MILLION) 157

  • TABLE 139 NETHERLANDS CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 158

  • TABLE 140 NETHERLANDS RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 158

  • TABLE 141 NETHERLANDS MULTIPLEX ASSAYS MARKET, BY END USER,

2017-2026 (USD MILLION) 159

  • TABLE 142 BELGIUM MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 160

  • TABLE 143 BELGIUM MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 160
  • TABLE 144 BELGIUM NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 161

  • TABLE 145 BELGIUM PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 161

  • TABLE 146 BELGIUM MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,

2017-2026 (USD MILLION) 162

  • TABLE 147 BELGIUM MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 162
  • TABLE 148 BELGIUM CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 163

  • TABLE 149 BELGIUM RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 163

  • TABLE 150 BELGIUM MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 164
  • TABLE 151 IRELAND MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 165

  • TABLE 152 IRELAND MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 165
  • TABLE 153 IRELAND NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 166

  • TABLE 154 IRELAND PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 166

  • TABLE 155 IRELAND MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 167
  • TABLE 156 IRELAND MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 167
  • TABLE 157 IRELAND CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 168

  • TABLE 158 IRELAND RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 168

  • TABLE 159 IRELAND MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 169
  • TABLE 160 AUSTRIA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 170

  • TABLE 161 AUSTRIA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 170
  • TABLE 162 AUSTRIA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 171

  • TABLE 163 AUSTRIA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 171

  • TABLE 164 AUSTRIA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 172
  • TABLE 165 AUSTRIA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 172
  • TABLE 166 AUSTRIA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 173
  • TABLE 167 AUSTRIA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 173

  • TABLE 168 AUSTRIA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 174
  • TABLE 169 REST OF EUROPE MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 175

  • TABLE 170 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 179
  • TABLE 171 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 179

  • TABLE 172 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 180
  • TABLE 173 ASIA-PACIFIC NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 180

  • TABLE 174 ASIA-PACIFIC PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 180

  • TABLE 175 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,

2017-2026 (USD MILLION) 181

  • TABLE 176 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY APPLICATION,

2017-2026 (USD MILLION) 181

  • TABLE 177 ASIA-PACIFIC CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 182

  • TABLE 178 ASIA-PACIFIC RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 182

  • TABLE 179 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY END USER,

2017-2026 (USD MILLION) 183

  • TABLE 180 CHINA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 184

  • TABLE 181 CHINA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 184
  • TABLE 182 CHINA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 185

  • TABLE 183 CHINA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 185

  • TABLE 184 CHINA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 186
  • TABLE 185 CHINA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 186
  • TABLE 186 CHINA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 187

  • TABLE 187 CHINA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 187

  • TABLE 188 CHINA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 188
  • TABLE 189 JAPAN MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 189

  • TABLE 190 JAPAN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 189
  • TABLE 191 JAPAN NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 190

  • TABLE 192 JAPAN PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 190

  • TABLE 193 JAPAN MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 191
  • TABLE 194 JAPAN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 191
  • TABLE 195 JAPAN CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 192

  • TABLE 196 JAPAN RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 192

  • TABLE 197 JAPAN MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 193
  • TABLE 198 SOUTH KOREA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 194

  • TABLE 199 SOUTH KOREA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 194
  • TABLE 200 SOUTH KOREA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 195
  • TABLE 201 SOUTH KOREA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 195

  • TABLE 202 SOUTH KOREA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,

2017-2026 (USD MILLION) 196

  • TABLE 203 SOUTH KOREA MULTIPLEX ASSAYS MARKET, BY APPLICATION,

2017-2026 (USD MILLION) 196

  • TABLE 204 SOUTH KOREA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 197

  • TABLE 205 SOUTH KOREA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 197

  • TABLE 206 SOUTH KOREA MULTIPLEX ASSAYS MARKET, BY END USER,

2017-2026 (USD MILLION) 198

  • TABLE 207 INDIA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 199

  • TABLE 208 INDIA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 199
  • TABLE 209 INDIA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 200

  • TABLE 210 INDIA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 200

  • TABLE 211 INDIA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 201
  • TABLE 212 INDIA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 201
  • TABLE 213 INDIA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 202

  • TABLE 214 INDIA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 202

  • TABLE 215 INDIA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 203
  • TABLE 216 SINGAPORE MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 204

  • TABLE 217 SINGAPORE MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 204
  • TABLE 218 SINGAPORE NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 205

  • TABLE 219 SINGAPORE PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 205

  • TABLE 220 SINGAPORE MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,

2017-2026 (USD MILLION) 206

  • TABLE 221 SINGAPORE MULTIPLEX ASSAYS MARKET, BY APPLICATION,

2017-2026 (USD MILLION) 206

  • TABLE 222 SINGAPORE CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 207

  • TABLE 223 SINGAPORE RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 207

  • TABLE 224 SINGAPORE MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 208
  • TABLE 225 AUSTRALIA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) 209
  • TABLE 226 AUSTRALIA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 209
  • TABLE 227 AUSTRALIA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 210

  • TABLE 228 AUSTRALIA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 210

  • TABLE 229 AUSTRALIA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,

2017-2026 (USD MILLION) 211

  • TABLE 230 AUSTRALIA MULTIPLEX ASSAYS MARKET, BY APPLICATION,

2017-2026 (USD MILLION) 211

  • TABLE 231 AUSTRALIA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 212

  • TABLE 232 AUSTRALIA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 212

  • TABLE 233 AUSTRALIA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 213
  • TABLE 234 THAILAND MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 214

  • TABLE 235 THAILAND MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 214
  • TABLE 236 THAILAND NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 215

  • TABLE 237 THAILAND PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 215

  • TABLE 238 THAILAND MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,

2017-2026 (USD MILLION) 216

  • TABLE 239 THAILAND MULTIPLEX ASSAYS MARKET, BY APPLICATION,

2017-2026 (USD MILLION) 216

  • TABLE 240 THAILAND CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 217

  • TABLE 241 THAILAND RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 217

  • TABLE 242 THAILAND MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 218
  • TABLE 243 MALAYSIA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 219

  • TABLE 244 MALAYSIA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 219
  • TABLE 245 MALAYSIA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 220

  • TABLE 246 MALAYSIA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 220

  • TABLE 247 MALAYSIA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,

2017-2026 (USD MILLION) 221

  • TABLE 248 MALAYSIA MULTIPLEX ASSAYS MARKET, BY APPLICATION,

2017-2026 (USD MILLION) 221

  • TABLE 249 MALAYSIA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 222

  • TABLE 250 MALAYSIA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 222

  • TABLE 251 MALAYSIA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 223
  • TABLE 252 INDONESIA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 224

  • TABLE 253 INDONESIA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 224
  • TABLE 254 INDONESIA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 225

  • TABLE 255 INDONESIA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 225

  • TABLE 256 INDONESIA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,

2017-2026 (USD MILLION) 226

  • TABLE 257 INDONESIA MULTIPLEX ASSAYS MARKET, BY APPLICATION,

2017-2026 (USD MILLION) 226

  • TABLE 258 INDONESIA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 227

  • TABLE 259 INDONESIA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 227

  • TABLE 260 INDONESIA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 228
  • TABLE 261 PHILIPPINES MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 229

  • TABLE 262 PHILIPPINES MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 229
  • TABLE 263 PHILIPPINES NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 230

  • TABLE 264 PHILIPPINES PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 230

  • TABLE 265 PHILIPPINES MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,

2017-2026 (USD MILLION) 231

  • TABLE 266 PHILIPPINES MULTIPLEX ASSAYS MARKET, BY APPLICATION,

2017-2026 (USD MILLION) 231

  • TABLE 267 PHILIPPINES CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 232

  • TABLE 268 PHILIPPINES RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 232

  • TABLE 269 PHILIPPINES MULTIPLEX ASSAYS MARKET, BY END USER,

2017-2026 (USD MILLION) 233

  • TABLE 270 REST OF ASIA-PACIFIC MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) 234
  • TABLE 271 SOUTH AMERICA MULTIPLEX ASSAYS MARKET, BY COUNTRY,

2017-2026 (USD MILLION) 238

  • TABLE 272 SOUTH AMERICA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 238

  • TABLE 273 SOUTH AMERICA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 238
  • TABLE 274 SOUTH AMERICA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 239
  • TABLE 275 SOUTH AMERICA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 239

  • TABLE 276 SOUTH AMERICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,

2017-2026 (USD MILLION) 240

  • TABLE 277 SOUTH AMERICA MULTIPLEX ASSAYS MARKET, BY APPLICATION,

2017-2026 (USD MILLION) 240

  • TABLE 278 SOUTH AMERICA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 241

  • TABLE 279 SOUTH AMERICA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 241

  • TABLE 280 SOUTH AMERICA MULTIPLEX ASSAYS MARKET, BY END USER,

2017-2026 (USD MILLION) 242

  • TABLE 281 BRAZIL MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 243

  • TABLE 282 BRAZIL MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 243
  • TABLE 283 BRAZIL NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 244

  • TABLE 284 BRAZIL PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 244

  • TABLE 285 BRAZIL MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION) 245
  • TABLE 286 BRAZIL MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 245
  • TABLE 287 BRAZIL CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 246

  • TABLE 288 BRAZIL RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 246

  • TABLE 289 BRAZIL MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) 247
  • TABLE 290 REST OF SOUTH AMERICA MULTIPLEX ASSAYS MARKET,

BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) 248

  • TABLE 291 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET,

BY COUNTRY, 2017-2026 (USD MILLION) 252

  • TABLE 292 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET,

BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) 252

  • TABLE 293 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 253

  • TABLE 294 MIDDLE EAST & AFRICA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 253
  • TABLE 295 MIDDLE EAST & AFRICA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 253
  • TABLE 296 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,

2017-2026 (USD MILLION) 254

  • TABLE 297 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET, BY APPLICATION,

2017-2026 (USD MILLION) 254

  • TABLE 298 MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 255

  • TABLE 299 MIDDLE EAST & AFRICA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 255
  • TABLE 300 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET, BY END USER,

2017-2026 (USD MILLION) 256

  • TABLE 301 SOUTH AFRICA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES,

2017-2026 (USD MILLION) 257

  • TABLE 302 SOUTH AFRICA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 257
  • TABLE 303 SOUTH AFRICA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION) 258
  • TABLE 304 SOUTH AFRICA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET,

BY TYPE, 2017-2026 (USD MILLION) 258

  • TABLE 305 SOUTH AFRICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY,

2017-2026 (USD MILLION) 259

  • TABLE 306 SOUTH AFRICA MULTIPLEX ASSAYS MARKET, BY APPLICATION,

2017-2026 (USD MILLION) 259

  • TABLE 307 SOUTH AFRICA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 260

  • TABLE 308 SOUTH AFRICA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET,

BY APPLICATION, 2017-2026 (USD MILLION) 260

  • TABLE 309 SOUTH AFRICA MULTIPLEX ASSAYS MARKET, BY END USER,

2017-2026 (USD MILLION) 261

  • TABLE 310 REST OF MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET,

BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) 262

LIST OF FIGURES

  • FIGURE 1 GLOBAL MULTIPLEX ASSAYS MARKET: SEGMENTATION 32
  • FIGURE 2 GLOBAL MULTIPLEX ASSAYS MARKET: DATA TRIANGULATION 35
  • FIGURE 3 GLOBAL MULTIPLEX ASSAYS MARKET: DROC ANALYSIS 36
  • FIGURE 4 GLOBAL MULTIPLEX ASSAYS MARKET: BOTTOM UP APPROACH 37
  • FIGURE 5 GLOBAL MULTIPLEX ASSAYS MARKET: TOP DOWN APPROACH 37
  • FIGURE 6 GLOBAL MULTIPLEX ASSAYS MARKET: INTERVIEW DEMOGRAPHICS 38
  • FIGURE 7 GLOBAL MULTIPLEX ASSAYS MARKET: DBMR MARKET POSITION GRID 39
  • FIGURE 8 GLOBAL MULTIPLEX ASSAYS MARKET: THE MARKET CHALLENGE MATRIX 40
  • FIGURE 9 GLOBAL MULTIPLEX ASSAYS MARKET: THE CATEGORY VS TIME GRID 41
  • FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF

GLOBAL MULTIPLEX ASSAYS MARKET 44

  • FIGURE 11 GLOBAL MULTIPLEX ASSAYS MARKET: SEGMENTATION 56
  • FIGURE 12 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE MULTIPLEX ASSAYS MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2019 TO 2026 57
  • FIGURE 13 USE OF MULTIPLEX ASSAYS IN COMPANION DIAGNOSTICS AND ADVANTAGES OVER SINGLEPLEX AND TRADITIONAL ASSAYS TO DRIVE THE MARKET FOR MULTIPLEX ASSAYS MARKET IN THE FORECAST PERIOD 2019 TO 2026 58
  • FIGURE 14 REAGENTS & CONSUMABLES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MULTIPLEX ASSAYS MARKET IN 2019 & 2026 59
  • FIGURE 15 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR MULTIPLEX ASSAYS MARKET IN THE FORECAST PERIOD FROM

2019 TO 2026 60

  • FIGURE 16 GLOBAL MULTIPLEX ASSAYS MARKET: BY PRODUCT & SERVICES, 2018 62
  • FIGURE 17 GLOBAL MULTIPLEX ASSAYS MARKET: BY TYPE, 2018 66
  • FIGURE 18 GLOBAL MULTIPLEX ASSAYS MARKET: BY TECHNOLOGY, 2018 72
  • FIGURE 19 GLOBAL MULTIPLEX ASSAYS MARKET: BY APPLICATION, 2018 78
  • FIGURE 20 GLOBAL MULTIPLEX ASSAYS MARKET: BY END USER, 2018 84
  • FIGURE 21 GLOBAL MULTIPLEX ASSAYS MARKET SNAPSHOT (2018) 90
  • FIGURE 22 GLOBAL MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY (2018) 91
  • FIGURE 23 GLOBAL MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY (2019) 91
  • FIGURE 24 GLOBAL MULTIPLEX ASSAYS MARKET: BY COUNTRY (2018 & 2026) 92
  • FIGURE 25 GLOBAL MULTIPLEX ASSAYS MARKET: BY PRODUCTS & SERVICES (2019 - 2026) 92
  • FIGURE 26 NORTH AMERICA MULTIPLEX ASSAYS MARKET SNAPSHOT (2018) 94
  • FIGURE 27 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY (2018) 95
  • FIGURE 28 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY (2019-2026) 95
  • FIGURE 29 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY COUNTRY (2018 & 2026) 96
  • FIGURE 30 NORTH AMERICA MULTIPLEX ASSAYS MARKET: BY PRODUCTS & SERVICES

(2019 - 2026) 96

  • FIGURE 31 EUROPE MULTIPLEX ASSAYS MARKET SNAPSHOT (2018) 117
  • FIGURE 32 EUROPE MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY (2018) 118
  • FIGURE 33 EUROPE MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY (2019-2026) 118
  • FIGURE 34 EUROPE MULTIPLEX ASSAYS MARKET: BY COUNTRY (2018 & 2026) 119
  • FIGURE 35 EUROPE MULTIPLEX ASSAYS MARKET: BY PRODUCTS & SERVICES (2019 - 2026) 119
  • FIGURE 36 ASIA PACIFIC MULTIPLEX ASSAYS MARKET SNAPSHOT (2018) 176
  • FIGURE 37 ASIA PACIFIC MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY (2018) 177
  • FIGURE 38 ASIA PACIFIC MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY (2019-2026) 177
  • FIGURE 39 ASIA PACIFIC MULTIPLEX ASSAYS MARKET: BY COUNTRY (2018 & 2026) 178
  • FIGURE 40 ASIA PACIFIC MULTIPLEX ASSAYS MARKET: BY PRODUCTS & SERVICES

(2019 - 2026) 178

  • FIGURE 41 SOUTH AMERICA MULTIPLEX ASSAYS MARKET SNAPSHOT (2018) 235
  • FIGURE 42 SOUTH AMERICA MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY (2018) 236
  • FIGURE 43 SOUTH AMERICA MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY (2019-2026) 236
  • FIGURE 44 SOUTH AMERICA MULTIPLEX ASSAYS MARKET: BY COUNTRY (2018 & 2026) 237
  • FIGURE 45 SOUTH AMERICA MULTIPLEX ASSAYS MARKET: BY PRODUCTS & SERVICES

(2019 - 2026) 237

  • FIGURE 46 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SNAPSHOT (2018) 249
  • FIGURE 47 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY (2018) 250
  • FIGURE 48 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY (2019-2026) 250
  • FIGURE 49 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET: BY COUNTRY (2018 & 2026) 251

FIGURE 50 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET:

BY PRODUCTS & SERVICES (2019 - 2026) 251

  • FIGURE 51 GLOBAL MULTIPLEX ASSAYS MARKET: COMPANY SHARE 2018 (%) 263
  • FIGURE 52 NORTH AMERICA MULTIPLEX ASSAYS MARKET: COMPANY SHARE 2018 (%) 264
  • FIGURE 53 EUROPE MULTIPLEX ASSAYS MARKET: COMPANY SHARE 2018 (%) 265
  • FIGURE 54 ASIA-PACIFIC MULTIPLEX ASSAYS MARKET: COMPANY SHARE 2018 (%) 266
目次

Global multiplex assays market is expected to register a healthy CAGR of 7.5% in the forecast period of 2019 to 2026. The new market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation

By Products & Services (Reagents & Consumables, Instruments & Accessories, Software & Services), Type (Nucleic Acid Multiplex Assays, Protein Multiplex Assays, Cell-Based Multiplex Assays), Technology (Protein Microarray, Polymerase Chain Reaction, Multiplex Real-Time PCR, Flow Cytometry, Fluorescence Detection, Luminescence, Others), Application (Clinical Diagnostics, Research & Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)

Major growing sectors under the market segmentation are as follows:

  • In products & services, reagents & consumables segment are dominating this market as the assays are widely accepted and applicable in various healthcare sectors the reagents & consumables holds the largest market share.
  • In type, the nucleic acid multiplex assays are highly sensitive and specific to diagnose human diseases such as cancer, autoimmune or infectious diseases.
  • In technology, the protein microarray is the emerging technology in the multiplex assays which offers characterization of hundreds of thousands of proteins in a highly parallel and high-throughput way. However, polymerase chain reaction is growing in the market due to its higher throughput and more information in fewer samples. As well as its time saving and cost effective.
  • In application, clinical diagnostics is growing more as there number of diseases increasing these days and treatment experiment is carries out more to treat the same and these processes are carries out under diagnostics division.
  • In end user, hospitals segment is growing as people suffering from problem visit hospitals as early as possible for the treatment. Increasing population visit hospitals with increase number of problems to get treated as early as possible and therefore the hospitals segment is growing higher as compare to other segment.

The key market players for global blood screening market are listed below:

  • BD
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Cepheid
  • Siemens AG
  • Hologic Inc.
  • Luminex Corporation.
  • MESO SCALE DIAGNOSTICS, LLC.
  • QIAGEN
  • PerkinElmer Inc.
  • Illumina, Inc.
  • AGENA BIOSCIENCE, INC.
  • Olink
  • Randox Laboratories Ltd.
  • Bio-Techne.
  • Agilent Technologies
  • Sysmex Corporation

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL MULTIPLEX ASSAYS MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATION
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHIC SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 RESEARCH METHODOLOGY
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7 DBMR MARKET POSITION GRID
  • 2.8 DBMR MARKET CHALLENGE MATRIX
  • 2.9 THE CATEGORY VS TIME GRID
  • 2.10 SECONDARY SOURCES
  • 2.11 ASSUMPTIONS

3 MARKET OVERVIEW

  • 3.1 DRIVERS
    • 3.1.1 USE OF MULTIPLEX ASSAYS IN COMPANION DIAGNOSTICS
    • 3.1.2 ADVANTAGES OVER SINGLEPLEX AND TRADITIONAL ASSAYS
    • 3.1.3 INCREASING AWARENESS ABOUT MULTIFACTORIAL NATURE OF VARIOUS DISEASES
    • 3.1.4 GROWING APPLICATIONS OF MULTIPLEX ASSAYS
  • 3.2 RESTRAINTS
    • 3.2.1 HIGH EQUIPMENT COSTS
    • 3.2.2 STRINGENT REGULATIONS AND STANDARDS
  • 3.3 OPPORTUNITIES
    • 3.3.1 INCREASING VALIDATION OF BIOMARKERS IN MOLECULAR AND PROTEIN DIAGNOSTICS
    • 3.3.2 NEWLY AVAILABLE OR LAUNCHED PANELS FOR THE ASSAYS
  • 3.4 CHALLENGES
    • 3.4.1 LACK OF PROFICIENT LABOUR TO HANDLE ADVANCED PROCEDURES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICES

  • 6.1 OVERVIEW
  • 6.2 REAGENTS & CONSUMABLES
  • 6.3 INSTRUMENTS & ACCESSORIES
  • 6.4 SOFTWARE & SERVICES

7 GLOBAL MULTIPLEX ASSAYS MARKET, BY TYPE

  • 7.1 OVERVIEW
  • 7.2 NUCLEIC ACID MULTIPLEX ASSAYS
    • 7.2.1 PLANAR NUCLEIC ASSAYS
    • 7.2.2 BEAD-BASED NUCLEIC ASSAYS
  • 7.3 PROTEIN MULTIPLEX ASSAYS
    • 7.3.1 PLANAR PROTEIN ASSAYS
    • 7.3.2 BEAD-BASED PROTEIN ASSAYS
  • 7.4 CELL-BASED MULTIPLEX ASSAYS

8 GLOBAL MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY

  • 8.1 OVERVIEW
  • 8.2 PROTEIN MICROARRAY
  • 8.3 POLYMERASE CHAIN REACTION
  • 8.4 MULTIPLEX REAL-TIME PCR
  • 8.5 FLOW CYTOMETRY
  • 8.6 FLUORESCENCE DETECTION
  • 8.7 LUMINESCENCE
  • 8.8 OTHERS

9 GLOBAL MULTIPLEX ASSAYS MARKET, BY APPLICATION

  • 9.1 OVERVIEW
  • 9.2 CLINICAL DIAGNOSTICS
    • 9.2.1 CANCER
    • 9.2.2 CARDIOVASCULAR DISEASES
    • 9.2.3 METABOLISM & ENDOCRINOLOGY DISORDERS
    • 9.2.4 INFECTIOUS DISEASES
    • 9.2.5 NERVOUS SYSTEM DISORDERS
    • 9.2.6 AUTOIMMUNE DISEASES
    • 9.2.7 ALLERGIES
    • 9.2.8 OTHERS

  • 9.3 RESEARCH & DEVELOPMENT
    • 9.3.1 DRUG DISCOVERY & DEVELOPMENT
    • 9.3.2 BIOMARKER DISCOVERY & VALIDATION

10 GLOBAL MULTIPLEX ASSAYS MARKET, BY END USER

  • 10.1 OVERVIEW
  • 10.2 HOSPITALS
  • 10.3 CLINICAL LABORATORIES
  • 10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIE
  • 10.5 RESEARCH INSTITUTES
  • 10.6 OTHERS

11 GLOBAL MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY

  • 11.1 OVERVIEW
  • 11.2 NORTH AMERICA
    • 11.2.1 U.S.
    • 11.2.2 CANADA
    • 11.2.3 MEXICO
  • 11.3 EUROPE
    • 11.3.1 GERMANY
    • 11.3.2 U.K.
    • 11.3.3 FRANCE
    • 11.3.4 ITALY
    • 11.3.5 SPAIN
    • 11.3.6 SWITZERLAND
    • 11.3.7 NETHERLANDS
    • 11.3.8 BELGIUM
    • 11.3.9 IRELAND
    • 11.3.10 AUSTRIA
    • 11.3.11 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 CHINA
    • 11.4.2 JAPAN
    • 11.4.3 SOUTH KOREA
    • 11.4.4 INDIA
    • 11.4.5 SINGAPORE
    • 11.4.6 AUSTRALIA
    • 11.4.7 THAILAND
    • 11.4.8 MALAYSIA
    • 11.4.9 INDONESIA
    • 11.4.10 PHILIPPINES
    • 11.4.11 REST OF ASIA-PACIFIC
  • 11.5 SOUTH AMERICA
    • 11.5.1 BRAZIL
    • 11.5.2 REST OF SOUTH AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 SOUTH AFRICA
    • 11.6.2 REST OF MIDDLE EAST & AFRICA

12 GLOBAL MULTIPLEX ASSAYS MARKET, COMPANY LANDSCAPE

  • 12.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 12.3 COMPANY SHARE ANALYSIS: EUROPE
  • 12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

13 COMPANY PROFILE

  • 13.1 THERMO FISHER SCIENTIFIC INC.
    • 13.1.1 COMPANY SNAPSHOT
    • 13.1.2 REVENUE ANALYSIS
    • 13.1.3 COMPANY SHARE ANALYSIS
    • 13.1.4 PRODUCT PORTFOLIO
    • 13.1.5 RECENT DEVELOPMENTS
  • 13.2 F. HOFFMANN-LA ROCHE LTD
    • 13.2.1 COMPANY SNAPSHOT
    • 13.2.2 REVENUE ANALYSIS
    • 13.2.3 COMPANY SHARE ANALYSIS
    • 13.2.4 PRODUCT PORTFOLIO
    • 13.2.5 RECENT DEVELOPMENTS
  • 13.3 BIO-RAD LABORATORIES, INC.
    • 13.3.1 COMPANY SNAPSHOT
    • 13.3.2 REVENUE ANALYSIS
    • 13.3.3 COMPANY SHARE ANALYSIS
    • 13.3.4 PRODUCT PORTFOLIO
    • 13.3.5 RECENT DEVELOPMENTS
  • 13.4 QIAGEN
    • 13.4.1 COMPANY OVERVIEW
    • 13.4.2 REVENUE ANALYSIS
    • 13.4.3 COMPANY SHARE ANALYSIS
    • 13.4.4 PRODUCT PORTFOLIO
    • 13.4.5 RECENT DEVELOPMENTS
  • 13.5 SIEMENS AG
    • 13.5.1 COMPANY SNAPSHOT
    • 13.5.2 REVENUE ANALYSIS
    • 13.5.3 PRODUCT PORTFOLIO
    • 13.5.4 RECENT DEVELOPMENTS
  • 13.6 ABCAM PLC.
    • 13.6.1 COMPANY SNAPSHOT
    • 13.6.2 REVENUE ANALYSIS
    • 13.6.3 PRODUCT PORTFOLIO
    • 13.6.4 RECENT DEVELOPMENTS
  • 13.7 AGENA BIOSCIENCE, INC.
    • 13.7.1 COMPANY SNAPSHOT
    • 13.7.2 GEOGRAPHICAL PRESENCE
    • 13.7.3 PRODUCT PORTFOLIO
    • 13.7.4 RECENT DEVELOPMENTS
  • 13.8 AGILENT TECHNOLOGIES, INC.
    • 13.8.1 COMPANY SNAPSHOT
    • 13.8.2 REVENUE ANALYSIS
    • 13.8.3 PRODUCT PORTFOLIO
    • 13.8.4 RECENT DEVELOPMENTS
  • 13.9 BD.
    • 13.9.1 COMPANY SNAPSHOT
    • 13.9.2 REVENUE ANALYSIS
    • 13.9.3 PRODUCT PORTFOLIO
    • 13.9.4 RECENT DEVELOPMENTS
  • 13.10 BIO-TECHNE.
    • 13.10.1 COMPANY SNAPSHOT
    • 13.10.2 REVENUE ANALYSIS
    • 13.10.3 PRODUCT PORTFOLIO
    • 13.10.4 RECENT DEVELOPMENTS
  • 13.11 BIOTEK INSTRUMENTS, INC.
    • 13.11.1 COMPANY SNAPSHOT
    • 13.11.2 GEOGRAPHICAL PRESENCE
    • 13.11.3 PRODUCT PORTFOLIO
    • 13.11.4 RECENT DEVELOPMENTS
  • 13.12 HOLOGIC INC.
    • 13.12.1 COMPANY SNAPSHOT
    • 13.12.2 REVENUE ANALYSIS
    • 13.12.3 PRODUCT PORTFOLIO
    • 13.12.4 RECENT DEVELOPMENTS
  • 13.13 ILLUMINA, INC.
    • 13.13.1 COMPANY SNAPSHOT
    • 13.13.2 REVENUE ANALYSIS
    • 13.13.3 PRODUCT PORTFOLIO
    • 13.13.4 RECENT DEVELOPMENTS
  • 13.14 LUMINEX CORPORATION.
    • 13.14.1 COMPANY SNAPSHOT
    • 13.14.2 REVENUE ANALYSIS
    • 13.14.3 PRODUCT PORTFOLIO
    • 13.14.4 RECENT DEVELOPMENTS
  • 13.15 MESO SCALE DIAGNOSTICS, LLC.
    • 13.15.1 COMPANY SNAPSHOT
    • 13.15.2 PRODUCT PORTFOLIO
    • 13.15.3 RECENT DEVELOPMENTS
  • 13.16 OLINK
    • 13.16.1 COMPANY SNAPSHOT
    • 13.16.2 GEOGRAPHICAL PRESENCE
    • 13.16.3 PRODUCT PORTFOLIO
    • 13.16.4 RECENT DEVELOPMENTS
  • 13.17 PERKINELMER INC.
    • 13.17.1 COMPANY SNAPSHOT
    • 13.17.2 REVENUE ANALYSIS
    • 13.17.3 PRODUCT PORTFOLIO
    • 13.17.4 RECENT DEVELOPMENTS
  • 13.18 QUANTERIX
    • 13.18.1 COMPANY SNAPSHOT
    • 13.18.2 REVENUE ANALYSIS
    • 13.18.3 PRODUCT PORTFOLIO
    • 13.18.4 RECENT DEVELOPMENTS
  • 13.19 QUEST DIAGNOSTICS INCORPORATED.
    • 13.19.1 COMPANY SNAPSHOT
    • 13.19.2 REVENUE ANALYSIS
    • 13.19.3 PRODUCT PORTFOLIO
    • 13.19.4 RECENT DEVELOPMENTS
  • 13.20 RANDOX LABORATORIES LTD.
    • 13.20.1 COMPANY SNAPSHOT
    • 13.20.2 GEOGRAPHICAL PRESENCE
    • 13.20.3 PRODUCT PORTFOLIO
    • 13.20.4 RECENT DEVELOPMENTS

  • 13.21 SEEGENE INC.
    • 13.21.1 COMPANY SNAPSHOT
    • 13.21.2 REVENUE ANALYSIS
    • 13.21.3 PRODUCT PORTFOLIO
    • 13.21.4 RECENT DEVELOPMENTS
  • 13.22 SYSMEX CORPORATION
    • 13.22.1 COMPANY SNAPSHOT
    • 13.22.2 REVENUE ANALYSIS
    • 13.22.3 PRODUCT PORTFOLIO
    • 13.22.4 RECENT DEVELOPMENTS

14 RELATED REPORTS